Status:

COMPLETED

Symptom Management App for Children at the Early Stage of Cancer Survivorship and Their Caregivers

Lead Sponsor:

Chinese University of Hong Kong

Conditions:

Oncology

Survivorship

Eligibility:

All Genders

9-16 years

Phase:

NA

Brief Summary

This pilot trial aims to determine the feasibility, usability, acceptability, and preliminary effect of the symptom management mHealth app. Participants meeting the aforementioned criteria (section d(...

Detailed Description

In Hong Kong, the incidence of paediatric cancer has been increasing in the past few years, from 180 new cancer cases in 2017 to 196 cases in 2019. The average 5-year survival rate for paediatric canc...

Eligibility Criteria

Inclusion

  • Chinese paediatric cancer survivors will be included if they
  • are aged 9 to 16 years,
  • are able to read Chinese and communicate in Chinese,
  • have completed active cancer treatment (within the previous 2 years), as early symptom management support is crucial to reduce the symptom burden in survivors and their caregivers throughout their survivorship, and
  • have a smartphone or tablet and are willing to install the mHealth app.
  • The primary caregiver of the paediatric cancer survivors (either the mother or father)
  • are able to read Chinese and communicate in Chinese, and
  • have a smartphone or tablet and are willing to install the mHealth app with their children surviving cancer

Exclusion

  • Chinese paediatric cancer survivors will be excluded if they
  • have cognitive impairments or psychiatric illnesses
  • are currently participating in other symptom management studies, or
  • have evidence of secondary malignancy or recurrence
  • The primary caregivers of the paediatric cancer survivors (either the mother or father) will be excluded if they have cognitive impairments or psychiatric illnesses.

Key Trial Info

Start Date :

August 17 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 2 2025

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT06015009

Start Date

August 17 2023

End Date

January 2 2025

Last Update

December 26 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Chinese University of Hong Kong

Hong Kong, Hong Kong